Chemi S.p.A.: Clinical Trials

4 trials sponsored by Chemi S.p.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 2

Follow Chemi S.p.A.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extended-release of Octreotide (LF-PB) for the Treatment of Seroma
extended release of octreotide, extended release of placebo - Seroma
Phase 2CompletedChemi S.p.A.482015-10-222017-02-02
Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.
Enoxaparin Sodium - Enoxaparin Sodium is Administered to Healthy Volunteers
Phase 1CompletedChemi S.p.A.472014-08-042020-10-20
A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting Conditions
Enoxaparin sodium - Clexane is Administered to Healthy Volunteers
Phase 1CompletedChemi S.p.A.142014-03-012020-11-12
Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea
LF-PB and Placebo, Placebo, LF-PB - Lymphorrhea
Phase 2CompletedChemi S.p.A.1142012-11-012014-07-29

Conditions studied

Seroma (1)

Interventions

Enoxaparin (2)  ·  enoxaparin sodium (2)

Countries

Italy (2)  ·  United Kingdom (2)

Top investigators

Paolo Bettica, MD (2)  ·  Paolo Carcoforo, MD (1)  ·  Paolo Carcoforo, Prof. (1)